Nitric oxide formation in acutely rejecting cardiac allografts correlates with GTP cyclohydrolase I activity

• Published in: Biochemical journal 2005-11, Vol.391 (Pt 3), p.541-547
• Main Authors: Pieper, Galen M, Nilakantan, Vani, Halligan, Nadine L N, Khanna, Ashwani K, Hilton, Gail, Vásquez-Vivar, Jeannette
• Format: Article
• Language: English
• Subjects: Animals; Biopterins - metabolism; Gene Expression Regulation, Enzymologic; Graft Rejection - enzymology; Graft Rejection - immunology; Graft Rejection - metabolism; GTP Cyclohydrolase - genetics; GTP Cyclohydrolase - metabolism; Heart Transplantation - immunology; Myocardium - enzymology; Myocardium - metabolism; Nitric Oxide - metabolism; Nitric Oxide Synthase Type II - genetics; Rats; Rats, Inbred Lew; Rats, Inbred WF; Time Factors
• ISSN: 0264-6021; 1470-8728
• DOI: 10.1042/BJ20050575

Inducible nitric oxide synthase (iNOS) is a prominent component of the complex array of mediators in acute graft rejection. While NO production is determined by iNOS expression, BH4 (tetrahydrobiopterin), a cofactor of iNOS synthesized by GTP cyclohydrolase I, has been considered critical in sustaining NO production. In the present study, we examined time-dependent changes in iNOS and GTP cyclohydrolase I in rat cardiac allografts. The increase in iNOS protein and mRNA in allografts was similar at POD4 (post-operative day 4) and POD6. However, the peak increase in intragraft NO level at POD4 was not sustained at POD6. This disparity could not be explained by any decrease in iNOS enzyme activity measured ex vivo with optimal amounts of substrate and cofactors. Lower iNOS activity could be explained by changes in total biopterin levels in allografts at POD4 that was decreased to baseline at POD6. Changes in biopterin production correlated with lower GTP cyclohydrolase I protein levels but not by any change in GTP cyclohydrolase I mRNA. Functionally, allografts displayed bradycardia and distended diastolic and systolic dimensions at POD6 but not at POD4. Likewise, histological rejection scores were increased at POD4 but with a secondary increased stage at POD6. It is hypothesized that the dissimilar amounts of NO at early and later stages of rejection is due to uncoupling of iNOS arising from disproportionate synthesis of BH4. These findings provide insight into a potential pathway regulating NO bioactivity in graft rejection. Such knowledge may potentially assist in the design of newer strategies to prevent acute graft rejection.